Hướng dẫn về việc sử dụng apheresis điều trị trong thực hành lâm sàng—Cách tiếp cận dựa trên bằng chứng từ Ủy ban ứng dụng apheresis của Hội khoa học Apheresis Hoa Kỳ

Klein HG, 1986, Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for Apheresis, J Clin Apher, 3, i

10.1002/jca.2920080402

10.1002/(SICI)1098-1101(2000)15:1/2<1::AID-JCA1>3.0.CO;2-R

10.1002/jca.20134

10.1002/jca.20131

10.1111/j.1432-2277.2003.tb00303.x

10.1038/sj.bmt.1703135

10.1046/j.1365-2141.2001.02587.x

10.1182/blood.V98.6.1687

10.1038/sj.bmt.1702121

10.1182/blood.V96.3.1150

10.1046/j.1365-3148.2001.00313.x

10.1002/jca.20002

10.1111/j.1600-6143.2004.00653.x

10.1097/00007890-200103150-00013

10.1002/lt.500060122

10.1056/NEJM200103153441102

10.1542/peds.2004-2038

10.1001/archneur.62.11.1673

10.1002/jca.20022

RamachandranNair R, 2005, Plasmapheresis in childhood acute disseminated encephalomyelitis, Indian Pediatr, 42, 479

10.1212/WNL.58.1.143

10.1136/pmj.79.927.11

10.1212/WNL.56.10.1313

10.1097/01.MAT.0000093748.55874.BA

10.1097/01.sla.0000124298.74199.e5

10.1007/s10047-004-0286-4

10.1111/j.1525-1594.2005.29079.x

10.1002/jca.20064

10.1111/j.1572-0241.2001.03706.x

10.1177/039139880002300708

10.1111/j.1749-6632.1999.tb08514.x

10.1002/(SICI)1098-1101(2000)15:1/2<53::AID-JCA5>3.0.CO;2-W

10.1212/WNL.35.8.1096

1986, The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development, JAMA, 256, 1333, 10.1001/jama.1986.03380100107031

10.1002/ana.410220612

10.1212/WNL.47.3.840

10.1111/j.1526-0968.2004.00183.x

Hughes RA, 2006, Intravenous immunoglobulin for Guillain‐Barre syndrome, Cochrane Database Syst Rev, CD002063

Raphael JC, 2002, Plasma exchange for Guillain‐Barre syndrome, Cochrane Database Syst Rev, CD001798

10.1056/NEJM199204233261705

10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O

10.1016/S0140-6736(96)09095-2

10.1046/j.1526-0968.2003.00089.x

10.1046/j.1523-1755.2003.00843.x

10.1111/j.1744-9987.1997.tb00148.x

10.1053/j.ajkd.2003.08.015

Little MA, 2004, Rapidly progressive glomerulonephritis: current and evolving treatment strategies, J Nephrol, 17, S10

10.1177/039139889902200205

10.1053/ajkd.2002.29874

Bandarenko N, 2001, Clinical Efficacy of plasma exchange in the treatment of ANCA‐associated vasculitis, J Clin Apher, 16, 101

Szczepiorkowski ZM, 2003, Apheresis: Principles and Practice, 375

Kaplan A, 1999, A Practical Guide to Therapeutic Plasma Exchange, 188

10.1681/ASN.2005080870

10.1097/00005792-198507000-00003

10.7326/0003-4819-134-11-200106050-00009

10.1046/j.1523-1755.2003.00241.x

10.1159/000166666

Walker RG, 1985, Clinical and morphological aspects of the management of crescentic anti‐glomerular basement membrane antibody (anti‐GBM) nephritis/Goodpasture's syndrome, Q J Med, 54, 75

Dessypris EN, 2005, Hematology: Basic Principle and Practice, 429

Drew MJ, 2003, Apheresis: Principles and Practice, 345

10.1002/(SICI)1098-1101(2000)15:1/2<28::AID-JCA4>3.0.CO;2-N

10.1111/j.1600-0609.2004.00320.x

10.1046/j.1537-2995.2000.40050543.x

Young N, 2005, Hematology: Basic Principles and Practice, 381

10.1002/jca.2920010206

Cunningham MJ, 2005, Hematology: Basic Principles and Practice, 693

10.1016/S0955-3886(00)00032-1

10.1053/j.seminhematol.2005.04.003

10.1097/00062752-200111000-00016

Rosse WF, 2002, Blood: Principles and Practice of Hematology, 1859

10.1053/j.seminhematol.2005.04.002

10.1046/j.1526-0968.2003.00004.x

10.1046/j.1537-2995.2000.40030375.x

10.1053/tmrv.2002.33437

Ritzenthaler J, 2003, The role of therapeutic erythrocytapheresis in the treatment of infection with Babesia microti in patients with significant co‐morbidities, J Clin Apher, 18, 95

10.1309/N3DP9MFPNUJD4XJY

10.1517/14656566.3.8.1109

Asherson RA, 1992, The catastrophic antiphospholipid syndrome, J Rheumatol, 19, 508

10.1016/j.autrev.2004.03.007

10.1191/0961203303lu394oa

10.1097/00005792-199805000-00005

10.1136/ard.2004.025759

10.1002/1096-8652(200010)65:2<154::AID-AJH11>3.0.CO;2-A

10.1002/ana.410360607

10.1093/brain/119.4.1055

10.1056/NEJMra041347

Mehndiratta MM, 2004, Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev, CD003906

10.1002/jca.20031

10.1097/01.moh.0000139998.68132.d2

10.1111/j.1423-0410.1991.tb00954.x

Huguet HC, 2004, Extracorporeal adsorption of anti‐factor VIII allo‐antibodies on randomly functionalized polystyrene resins, Thromb Haemost, 91, 259, 10.1160/TH03-07-0430

10.1046/j.1365-2141.2001.02510.x

Kreuz W, 2003, Epidemiology of inhibitors and current treatment strategies, Haematologica, 88, EREP04

10.1001/archderm.139.3.391

10.1046/j.1537-2995.1980.20280169957.x

10.1046/j.1526-0968.2002.00400.x

10.1046/j.1526-0968.2001.005002134.x

Russo GE, 1996, Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment, Transfus Sci, 17, 499, 10.1016/S0955-3886(96)90084-3

10.1016/S0190-9622(97)80226-5

10.1056/NEJM198702053160603

10.1016/S1473-0502(02)00010-1

10.1016/S1473-0502(02)00103-9

10.1016/j.clon.2004.11.010

10.1080/10428190310001623766

10.1111/j.1396-0296.2003.01646.x

10.1007/BF01648884

10.1111/j.1365-2141.2005.05535.x

Pollari G, 1999, The role of erythrocytapheresis in secondary erythrocytosis therapy, Clin Hemorheol Microcirc, 21, 353

10.1016/S0955-3886(00)00042-4

10.1055/s-2003-44560

10.1007/BF01737944

10.1046/j.1525-1594.2002.06837.x

10.1111/j.1526-0968.2003.00120.x

10.1046/j.1526-0968.2000.004005382.x

10.1016/S0021-9150(02)00251-4

10.1016/j.amjcard.2005.06.012

10.1111/j.1526-0968.2001.00318.x

Cameron JS, 2003, Focal segmental glomerulosclerosis in adults, Nephrol Dial Transplant, 18, vi45, 10.1093/ndt/gfg1058

10.1111/j.1600-6143.2005.01112.x

10.1093/ndt/gfh320

10.1517/14656566.6.9.1539

Newstead CG, 2003, Recurrent disease in renal transplants, Nephrol Dial Transplant, 18, vi68

10.1056/NEJM199604043341402

Sharma M, 1999, “The FSGS factor:” enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma, J Am Soc Nephrol, 10, 552, 10.1681/ASN.V103552

10.1038/sj.ki.5000160

Greinix HT, 2006, The effect of intensified extracorporeal photochemotherapy on long‐term survival in patients with severe acute graft‐versus‐host disease, Haematologica, 91, 405

10.1111/j.1365-2141.2005.05586.x

10.1038/sj.bmt.1704851

10.1046/j.1365-2141.2003.04401.x

10.1182/blood-2002-11-3351

10.1111/j.1365-2133.2005.06857.x

10.1016/j.bbmt.2005.11.009

10.1182/blood-2005-09-3907

10.1016/j.bbmt.2005.11.005

10.1034/j.1399-0012.2000.140211.x

10.1056/NEJM199812103392404

10.1016/j.healun.2005.10.004

10.1067/mtc.2003.168

10.1097/01.TP.0000157278.02848.C7

10.1002/jca.20089

10.1016/j.carpath.2005.05.001

10.1086/319269

10.1046/j.1526-0968.2002.00390.x

10.1056/NEJMra020528

10.1016/j.bbmt.2005.06.001

Zheng X, 2006, Clinical Hematology, 802

10.1182/blood-2003-01-0193

Abla O, 2004, Complications of hyperleukocytosis and leukapheresis in pediatric acute leukemia, Blood, 104, 1963, 10.1182/blood.V104.11.1963.1963

10.3109/10428190109097677

Kuruvilla JG, 2002, Outcome for patients with acute myelogenous leukemia and hyperleukocytosis requiring urgent leukapheresis at diagnosis, Blood, 100, 4598

10.1002/pbc.20178

10.1046/j.1526-0968.2002.00402.x

10.1182/blood.V97.7.2121

10.1111/j.1600-0609.2005.00421.x

Bolan C, 2002, Intensive, long‐term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy, J Clin Endocrinol Metab, 87, 380, 10.1210/jcem.87.1.8176

Chait A, 1992, Chylomicronemia syndrome, Adv Intern Med, 37, 249

10.1097/00006676-199607000-00013

10.1016/0016-5085(93)90366-K

10.1002/jca.10063

10.1002/jca.10047

10.3748/wjg.v10.i15.2272

10.1111/j.0954-6820.1985.tb01646.x

Bloch KJ, 1973, Hyperviscosity syndromes associated with immunoglobulin abnormalities, Semin Hematol, 10, 113

Buskard NA, 1977, Plasma exchange in the long–term management of Waldenstrom's macroglobulinemia, Can Med Assoc J, 117, 135

10.1001/jama.1965.03080190030008

10.1055/s-2007-994921

10.1172/JCI108568

10.7326/0003-4819-58-5-789

Russell JA, 1977, Plasma exchange in malignant paraproteinemias, Exp Hematol, 5, 105S

10.1046/j.1365-2141.2003.04131.x

10.1182/blood-2004-12-4598

10.1001/archinte.160.11.1630

10.1182/blood.V88.1.3.3

Handelsman H, 1990, Protein A columns for the treatment of patients with idiopathic thrombocytopenic purpura and other indications, Health Technol Assess Rep, 1

10.1002/ajh.10312

10.1111/j.1537-2995.2004.04333.x

10.1182/blood.V79.9.2237.2237

10.1212/WNL.47.3.678

Lambert EH, 1956, Defect of neuromuscular conduction associated with malignant neoplasms, Am J Physiol, 187, 612

10.1056/NEJM199506013322203

10.1111/j.1749-6632.1998.tb11023.x

10.1212/WNL.34.4.480

10.1111/j.1749-6632.1998.tb11024.x

10.1007/s10227-003-5005-x

10.1002/jca.10009

10.1378/chest.115.5.1459

10.1016/S0022-5223(99)70241-2

Villanueva J, 2000, Extracorporeal photopheresis for the treatment of lung allograft rejection, Ann Transplant, 5, 44

10.1016/j.healun.2004.11.068

10.1542/peds.2005-0314

10.1179/000349803225001364

10.1136/bmj.331.7512.337

10.1086/339810

Pepkowitz S, 2003, Apheresis: Principles and Practice, 411

10.1016/0140-6736(91)93389-Q

10.1056/NEJM198301273080401

10.1056/NEJM200009283431307

10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q

10.1212/WNL.32.7.739

10.1212/WNL.35.3.312

10.1046/j.1526-0968.2000.004004280.x

Gajdos P, 2002, Plasma exchange for myasthenia gravis, Cochrane Database Syst Rev, CD002275

Gajdos P, 2003, Intravenous immunoglobulin for myasthenia gravis, Cochrane Database Syst Rev, CD002277

10.1001/archinte.1990.00390160111022

10.1034/j.1600-0609.2000.90221.x

10.1016/S0272-6386(87)80007-0

10.1159/000013424

Pasquali S, 1985, Plasma exchange therapy in rapidly progressive renal failure due to multiple myeloma, Int J Artif Organs, 8, 27

10.1038/ki.1988.127

Zucchelli P, 1984, Plasma exchange therapy in acute renal failure due to light chain myeloma, Trans Am Soc Artif Intern Organs, 30, 36

10.7326/0003-4819-143-11-200512060-00005

10.1002/jca.20068

Hay SN, 2002, Plasma exchange for rapidly progressive myeloma kidney, J Clin Apher, 17, 142

Rubik J, 2003, Clinical aspects of plasmapheresis therapy in children: single center experience, Pol Merkuriusz Lek, 14, 304

Linden CH, 2004, Harrison's Principles of Internal Medicine

10.1212/WNL.44.12.2241

Dalmau JO, 1997, Paraneoplastic syndromes affecting the nervous system, Semin Oncol, 24, 318

10.1002/ana.410370711

10.1212/WNL.40.10.1621

10.1212/WNL.42.3.536

10.1016/S0889-8588(05)70375-0

10.1212/WNL.44.12.2412

10.1136/jnnp.60.4.388

10.1002/1097-0142(19950401)75:7<1678::AID-CNCR2820750719>3.0.CO;2-2

10.1002/(SICI)1097-0142(19961115)78:10<2153::AID-CNCR16>3.0.CO;2-Y

10.1001/jama.1992.03490150121036

Arnold PD, 2001, Is obsessive‐compulsive disorder an autoimmune disease?, CMAJ, 165, 1353

10.1177/08830738050200050601

10.1001/archpedi.156.4.356

10.1016/S0140-6736(98)12297-3

Sasson Y, 1997, Epidemiology of obsessive‐compulsive disorder: a world view, J Clin Psychiatry, 58, 7

10.1038/sj.mp.4001542

10.1176/ajp.155.2.264

10.1001/archderm.1979.04010060036025

10.1001/archderm.1988.01670110019004

10.1111/j.1365-2133.1979.tb05571.x

10.1001/archderm.1983.01650270033013

10.1159/000249707

10.1111/j.1346-8138.2001.tb00054.x

10.1067/mjd.2000.109297

10.1016/S0190-9622(08)80854-7

10.1159/000018090

10.1111/j.1469-8749.1989.tb08416.x

10.1111/j.1600-0404.1985.tb01541.x

10.1111/j.1600-0404.1996.tb07051.x

10.1136/jnnp.54.7.614

10.1159/000115788

10.1007/BF02191145

Siegmund JB, 1995, Cascade filtration in Refsum's disease, Nephrol Dial Transplant, 10, 117

10.1002/(SICI)1098-1101(1999)14:4<181::AID-JCA5>3.0.CO;2-Z

10.1093/qjmed/94.8.403

10.1002/(SICI)1098-1101(1999)14:3<149::AID-JCA8>3.0.CO;2-9

10.1111/j.1600-0404.1998.tb00636.x

10.1002/ana.410370705

Yeung KB, 1991, The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings, J Neurol, 238, 383, 10.1007/BF00319857

10.1056/NEJM199111213252105

Ashbury AK, 2004, Harrison's Principles of Internal Medicine, 2498

10.1046/j.1526-0968.2003.00028.x

McLeod BC, 2003, Apheresis: Principles and Practice, 321

10.4065/81.5.693

10.1097/01.wco.0000245368.36576.0d

10.1182/blood.V68.2.347.347

10.1002/ajh.20093

10.1016/S1473-0502(03)00049-1

10.1097/00043426-200312001-00009

Bussel J, 2005, Hematology: Basic Principles and Practice, 2269

George JN, 2001, Williams Hematology, 1495

Levy JB, 1997, Still a role for plasma exchange in rapidly progressive glomerulonephritis?, J Nephrol, 10, 7

10.1212/WNL.46.1.242

10.1212/WNL.51.1.302

10.1097/00019052-199604000-00002

10.1212/01.WNL.0000099074.04539.E0

10.1212/WNL.8.6.435

10.1097/00019052-199604000-00015

10.1016/S0140-6736(76)92906-8

10.1136/bmj.1.6070.1185

Kirsten GF, 1995, The outcome of babies of mothers with severe rhesus incompatibility treated at Tygerberg Hospital, 1980–1993, S Afr Med J, 85, 1091

10.1016/S0029-7844(02)02180-4

10.1515/jpme.1997.25.1.85

10.1111/j.1365-2141.1980.tb07185.x

10.1111/j.1432-2277.2005.00257.x

10.1111/j.1600-6143.2005.01178.x

Blake P, 1990, Plasma exchange in acute renal transplant rejection, Prog Clin Biol Res, 337, 249

10.1016/j.transproceed.2004.12.063

10.1111/j.1600-6143.2004.00500.x

10.1016/S0041-1345(00)02096-0

10.1034/j.1600-6143.2003.00072.x

10.1111/j.1744-9987.2005.00306.x

10.1097/00002281-200305000-00005

10.1002/1529-0131(199910)42:10<2153::AID-ANR16>3.0.CO;2-W

10.1046/j.1526-0968.2001.005002079.x

10.1046/j.1526-0968.2001.005002084.x

Wiesenhutter CW, 1994, Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial, J Rheumatol, 21, 804

Genovese MC, 2005, Kelley's Textbook of Rheumatology, 1079

Sasso EH, 2000, Prosorba treatment of rheumatoid arthritis induces anti‐staphylococcal protein A activity earlier in responders than non‐responders, Arthritis Rheum, 43, S290

10.1016/S1473-0502(01)00078-7

10.1002/art.1780240903

10.1002/jca.2920010404

Weiner SR, 1987, Preliminary report on a controlled trial of apheresis in the treatment of scleroderma, Arthritis Rheum, 30, S24

10.1007/s00134-002-1410-7

10.1046/j.1526-0968.2002.00449.x

10.1097/00130478-200301000-00002

10.1016/S1473-0502(03)00100-9

10.1046/j.1526-0968.2001.005002123.x

10.1016/j.disamonth.2003.12.003

10.1007/s001340051200

10.1056/NEJM199807023390102

10.1002/(SICI)1098-1101(2000)15:1/2<129::AID-JCA7>3.0.CO;2-H

10.1182/blood.V83.4.1136.1136

Ohene‐Frempong K, 2001, Indications for red cell transfusion in sickle cell disease, Semin Hematol, 38, 5, 10.1053/shem.2001.20139

10.1182/blood.V76.7.1431.1431

Thurston GB, 2004, Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood, Clin Hemorheol Microcirc, 30, 83

10.1056/NEJM200006223422502

10.1016/S0037-1963(01)90057-5

10.1136/bmj.327.7424.1151

10.1046/j.1526-0968.2002.00396.x

10.1136/jnnp.65.5.633

10.1212/WNL.41.10.1588

10.1056/NEJMoa01167

10.1016/S0025-6196(12)65339-7

10.1016/S0025-6196(12)61012-X

10.1055/s-2008-1041073

10.1212/01.WNL.0000073143.53337.DD

10.1016/j.berh.2005.05.006

10.1016/S0140-6736(83)91561-1

10.1046/j.1525-1594.2000.06623.x

10.1177/096120339500400607

10.1006/jaut.1998.0229

10.1046/j.1526-0968.2003.00040.x

10.1007/s00296-005-0031-1

10.1046/j.1526-0968.2003.00032.x

10.1007/978-1-4684-5718-6_21

10.1007/s001050050775

Hahn BH, 2004, Harrison's Principles of Internal Medicine

Adami R, 1993, Therapeutic thrombocytapheresis: a review of 132 patients, Int J Artif Organs, 16, 183, 10.1177/039139889301605s40

10.1002/1097-0142(19930815)72:4<1209::AID-CNCR2820720413>3.0.CO;2-4

10.1046/j.1526-0968.2002.00394.x

10.1056/NEJMra035363

10.1046/j.1365-2141.1997.4823285.x

10.1111/j.1365-2141.2004.05277.x

10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z

10.1056/NEJM199108083250605

10.1038/35097008

10.1056/NEJM199108083250604

10.1056/NEJM199811263392203

10.1111/j.1365-2141.2004.04836.x

10.1002/jca.1003

10.1111/j.1444-0903.2004.00600.x

10.1002/jca.20014

10.1016/j.jemermed.2004.08.020

10.1080/17843286.1988.11717954

10.1097/00003246-198406000-00016

10.1111/j.1365-2125.1991.tb05548.x

Jameson JL, 2004, Harrison's Principles of Internal Medicine

10.1358/mf.2001.23.3.627947

10.1002/jca.20045

10.1016/S0735-1097(00)00568-4

10.1016/S0735-1097(01)01794-6

10.1016/j.autrev.2003.10.005

10.1016/S0896-8411(03)00042-8

10.1161/01.CIR.101.4.385

10.1161/01.CIR.0000036746.49449.64

10.1016/j.ahj.2004.11.002

10.1161/01.CIR.103.22.2681

10.1161/01.CIR.95.8.1994

10.1159/000080079

10.1053/j.gastro.2004.01.063

10.1097/01.MIB.0000195386.19268.b3

10.1097/01.MIB.0000195387.26892.22

10.1046/j.1526-0968.2003.00012.x

10.2174/1381612033391928

10.1002/jca.1000

10.1111/j.1365-2036.2004.02189.x

10.3748/wjg.v12.i4.520

Brunner R, 1996, Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome, Transfus Sci, 17, 493, 10.1016/S0955-3886(96)90083-1

10.1177/039139889501801208

10.1097/00006982-200009000-00009

10.1007/s00347-002-0614-0

10.1046/j.1526-0968.2003.00027.x

10.1002/jca.20047

Pulido JS, 2002, Multicenter prospective, randomized, double‐masked, placebo‐controlled study of Rheopheresis to treat nonexudative age‐related macular degeneration: interim analysis, Trans Am Ophthalmol Soc, 100, 85

Fell A, 2000, Effect of rheopheresis on visual function in patients with early age‐related macular degeneration, Invest Ophthalmol Vis Sci, 41, S181

Soudavar F, 1998, Changes of retinal haemodynamics after elimination of high molecular weight proteins and lipids in patients with age‐related macular degeneration (AMD), Invest Ophthalmol Vis Sci, 39, S386

Swartz M, 1999, Treatment of non‐exudative age‐related macular degeneration using membrane differential filtration apheresis, Invest Ophthalmol Vis Sci, 40, S319

Widder RA, 2000, Long‐term treatment of age‐related macular degeneration with extracorporeal apheresis, Ophthalmologe, 97, S172

Widder RA, 2002, The treatment of age‐related macular degeneration (ARMD) with extracorporeal treatment procedures, Invest Ophthalmol Vis Sci, 43, 2906